[1]周倩,余红霞,巨姣春,等.血液肿瘤化疗患者继发糖尿病的危险因素研究及预测模型构建[J].国际内分泌代谢杂志,2021,41(05):439-444.[doi:10.3760/cma.j.cn121383-20201015-10017]
 Zhou Qian,Yu Hongxia,Ju Jiaochun,et al.Risk factors of secondary diabetes in patients with hematologic tumor received chemotherapy and construction of prediction model[J].International Journal of Endocrinology and Metabolism,2021,41(05):439-444.[doi:10.3760/cma.j.cn121383-20201015-10017]
点击复制

血液肿瘤化疗患者继发糖尿病的危险因素研究及预测模型构建()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年05期
页码:
439-444
栏目:
“特殊类型糖尿病”专题
出版日期:
2021-09-30

文章信息/Info

Title:
Risk factors of secondary diabetes in patients with hematologic tumor received chemotherapy and construction of prediction model
作者:
周倩12余红霞2巨姣春2贺章亚1陈方尧3罗小琴1
1西安交通大学公共卫生学院营养与食品安全系 710061; 2空军军医大学第二附属医院唐都医院血液内科,西安 710038; 3西安交通大学公共卫生学院流行病与卫生统计学系 710061
Author(s):
Zhou Qian12 Yu Hongxia2 Ju Jiaochun2 He Zhangya1 Chen Fangyao3 Luo Xiaoqin1.
1Department of Nutrition and Food Safety, School of Public Health, Xi'an Jiaotong University, Xi'an 710061, China; 2Department of Hematology, Tangdu Hospital, the Second Affiliated Hospital of the Air Force Medical University, Xi'an 710038, China; 3Department of Epidemiology and Health Statistics, School of Public Health, Xi'an Jiaotong University, Xi'an 710061, China
关键词:
血液肿瘤 继发性糖尿病 危险因素 预测模型
Keywords:
Hematologic tumor Secondary diabetes Risk factors Prediction model
DOI:
10.3760/cma.j.cn121383-20201015-10017
摘要:
目的 探讨血液肿瘤化疗患者继发糖尿病的危险因素并建立预测模型。方法 回顾性分析唐都医院2017年1月至2019年6月血液肿瘤化疗患者769例,根据是否继发糖尿病分为病例组(n=289)和对照组(n=480)。使用logistic回归分析法建立继发糖尿病风险预测模型,Hosmer-Lemeshow拟合优度检验评价模型校准度,使用曲线下面积(AUC)评价模型区分度,后续收集2019年7—12月183例患者资料进行模型外部验证。结果 建立了由糖尿病家族史、高血压史等7项指标组成的继发糖尿病风险预测模型。模型AUC为0.917,灵敏度为89.3%,特异度为83.1%。结论 对于有糖尿病家族史、高血压史、体重指数(BMI)≥24 kg/m2、高龄、口服激素且时间长用量大的血液肿瘤化疗患者应警惕继发性糖尿病的发生,本预测模型具有较好的精确度和区分度。
Abstract:
Objective To explore the risk factors of secondary diabetes in patients with hematologic tumor and treated by chemotherapy and establish a prediction model.Methods A retrospective analysis was performed on 769 patients with hematologic tumor in Tangdu Hospital from January 2017 to June 2019. The patients were divided into case group(n=289)and control group(n=480)according to whether they had secondary diabetes. Logistic regression analysis was used to establish the risk prediction model for secondary diabetes. Hosmer-Lemeshow goodness of fit test was used to evaluate the model calibration degree, and area under receiver(AUC)of Charateristic curve(ROC curve)was used to evaluate the differentiation degree. The data of 183 patients from July to December 2019 were collected for external validation of the model.Results A risk prediction model of secondary diabetes was established consisted of 7 indicators including family history of diabetes, hypertension, etc. AUC of this model was 0.917 with high sensitivity(89.3%)and specificity(83.1%).Conclusion Patients with family history of diabetes, history of hypertension, body mass index(BMI)≥24 kg/m2, advanced age and oral hormone treatment for a long time with large dosage should be vigilant the occurrence of secondary diabetes in patients with nematologic tumor and treated by chemotherapy. The prediction model has good accuracy and discrimination.

参考文献/References:

[1] 单忠艳.根据2018年美国糖尿病学会标准诊断中国糖尿病患病率:全国横断面研究[J].国际内分泌代谢杂志,2020,40(5):314-314.DOI:10.3760/cma.j.issn.1673-4157.2020.05.101.
[2] 肖春燕,梁喜平,郭冰凌,等.非霍奇金淋巴瘤CHOP样方案化疗后继发类固醇糖尿病的相关危险因素分析[J].第三军医大学学报,2020,42(17):1743-1749.DOI:10.16016/j.1000-5404.202004073.
[3] Suh S,Park MK.Glucocorticoid-induced diabetes mellitus:an important but overlooked problem[J].Endocrinol Metab(Seoul),2017,32(2):180-189.DOI:10.3803/EnM.2017.32.2.180.
[4] 陈彬,康德英.研究对象样本量的计算方法//王家良,主编.临床流行病学:临床科研设计、测量与评价[M].4版.上海:上海科学技术出版社,2014:56-74.
[5] 沈悌,赵永强.血液病诊断及疗效标准[M].第4版.北京:科学出版社,2018:89-296.
[6] Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15(7):539-553.DOI:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO; 2-S.
[7] 李豫川,曹冰燕,巩纯秀,等.以住院患儿为基础的儿童继发性糖尿病患病率调查及相关因素分析[J].中华糖尿病杂志,2013,5(8):477-480.DOI:10.3760/cma.j.issn.1674-5809.2013.08.006.
[8] 罗凯明,蒋晓红,华飞.糖尿病对肿瘤发生的影响及机制[J].国际内分泌代谢杂志,2020,40(2):125-128,133.DOI:10.3760/cma.j.cn121383-20190725-07069.
[9] 索珊珊.血液系统肿瘤化疗继发糖尿病临床研究[D].浙江大学,2015.
[10] Lu HJ,Huang YC,Liu CY,et al.Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era[J].Ann Hematol,2013,92(11):1495-1501.DOI:10.1007/s00277-013-1789-y.
[11] 邢昌赢,徐一力.类固醇糖尿病研究进展[J].肾脏病与透析肾移植杂志,2019,28(5):446-447.DOI:10.3969/j.issn.1006-298X.2019.05.009.
[12] 刘华青,张敏,林玲,等.蚌埠市中青年人群未诊断糖尿病风险因素研究[J].蚌埠医学院报,2019,44(2):239-242.DOI:10.13898/j.cnki.issn.1000-2200.2019.02.030.
[13] Zhou K,Donnelly LA,Morris AD,et al.Clinical and genetic determinants of progression of type 2 diabetes: a DIRECT study[J].Diabetes Care,2014,37(3):718-724.DOI:10.2337/dc13-1995.
[14] Li S,Guo S,He F,et al.Prevalence of diabetes mellitus and impaired fasting glucose,associated with risk factors in rural Kazakh adults in Xinjiang,China[J].Int J Environ Res Public Health,2015,12(1):554-565.DOI:10.3390/ijerph120100554.
[15] 田园梦,井丽,张博强,等.2018年辽宁省农村40岁及以上居民糖尿病患病率及其相关危险因素分析[J].现代预防医学,2020,47(7):1300-1304.
[16] Berentzen TL,Jakobsen MU,Halkjaer J,et a1.Changes in waist circumference and the incidence of diabetes in middle-aged men and women[J].PLoS One,2011,6(8):e23104.DOI:10.1371/journal.pone.0023104.
[17] 华优,王敏,高亚丽,等.糖皮质激素诱发类固醇糖尿病38例临床分析[J].中华皮肤科杂志,2018,51(4):269-273.DOI:10.3760/cma.j.issn.0412-4030.2018.04.006.
[18] 王中京,赵湜,邓艾平,等.糖皮质激素治疗特发性血小板减少性紫癜患者血糖变化特点及对策[J].中国药房,2011,22(14):1304-1306.DOI:CNKI:SUN:ZGYA.0.2011-14-025.

备注/Memo

备注/Memo:
通信作者:罗小琴,Email:luoxiaoqin2012@mail.xjtu.edu.cn
更新日期/Last Update: 2021-10-10